Safety and tolerability of subcutaneous trastuzumab (H SC) self-administered at home via single-use injection device (SID) in patients (pts) with HER2-positive early breast cancer (EBC): Primary and final analysis of the open-label, phase IIIB HOMERUS study

被引：0

作者：

ten Tije, A. J. ^{[1
]}

van Steenis, S. ^{[2
]}

Briers, J. ^{[2
]}

Elsten, E. M. P. ^{[1
]}

机构：

[1] Amphia Hosp, Dept Med Oncol, Breda, Netherlands

[2] Roche Netherlands BV, Med Affairs, Woerden, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

223P

引用

页码：S330 / S330

页数：1